Company / EPS (Diluted)
Sigyn Therapeutics, Inc. EPS (Diluted) History
FY2015-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$0.04
FY2019
5-year range
-$0.09 / -$0.01
FY2015-FY2019
Trend
+55.6%
vs FY2018
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $-0.01 to $-0.04 over the past 4 years.
Based on SEC 10-K filings.
-0.04 in FY2019.
Declined from $-0.01 to $-0.04 over the past 4 years.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2019, eps (diluted) increased 55.6% year-over-year.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2019 | -$0.04 | +55.6% |
| FY2018 | -$0.09 | -800.0% |
| FY2015 | -$0.01 | - |
As of FY2019 · SEC 10-K · Updated Jun 29, 2026